Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-07-22

Clinical Trial Update: Topiramate on Gambling-Related Behaviours [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topiramate for gambling-related behaviours was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Gambling | Phase 2 | Status: WITHDRAWN